nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—type 2 diabetes mellitus—obesity	0.361	1	CtDrD
Bromocriptine—DRD4—obesity	0.0456	0.189	CbGaD
Bromocriptine—HTR1B—obesity	0.0405	0.168	CbGaD
Bromocriptine—DRD1—obesity	0.0386	0.16	CbGaD
Bromocriptine—ADRB1—obesity	0.0358	0.148	CbGaD
Bromocriptine—HTR2C—obesity	0.033	0.137	CbGaD
Bromocriptine—DRD2—obesity	0.0272	0.113	CbGaD
Bromocriptine—ADRA1B—Phendimetrazine—obesity	0.0253	0.106	CbGbCtD
Bromocriptine—DRD1—Phenylpropanolamine—obesity	0.0228	0.0952	CbGbCtD
Bromocriptine—HTR2A—obesity	0.021	0.087	CbGaD
Bromocriptine—ADRA1A—Phendimetrazine—obesity	0.0199	0.0833	CbGbCtD
Bromocriptine—ADRB1—Phenylpropanolamine—obesity	0.0196	0.082	CbGbCtD
Bromocriptine—ADRA2C—Methamphetamine—obesity	0.0191	0.0798	CbGbCtD
Bromocriptine—ADRA2B—Methamphetamine—obesity	0.0181	0.0757	CbGbCtD
Bromocriptine—ADRA2A—Benzphetamine—obesity	0.0158	0.0658	CbGbCtD
Bromocriptine—ADRA1A—Benzphetamine—obesity	0.0151	0.0631	CbGbCtD
Bromocriptine—ADRA2A—Phenylpropanolamine—obesity	0.015	0.0628	CbGbCtD
Bromocriptine—ADRA1A—Phenylpropanolamine—obesity	0.0144	0.0602	CbGbCtD
Bromocriptine—ADRA2A—Methamphetamine—obesity	0.0126	0.0526	CbGbCtD
Bromocriptine—CYP1A2—Phentermine—obesity	0.00636	0.0266	CbGbCtD
Bromocriptine—CYP1A2—Phenylpropanolamine—obesity	0.00607	0.0254	CbGbCtD
Bromocriptine—CYP1A2—Bupropion—obesity	0.00541	0.0226	CbGbCtD
Bromocriptine—CYP3A4—Sibutramine—obesity	0.0044	0.0184	CbGbCtD
Bromocriptine—CYP1A2—Cimetidine—obesity	0.00397	0.0166	CbGbCtD
Bromocriptine—ABCB1—Cimetidine—obesity	0.00347	0.0145	CbGbCtD
Bromocriptine—CYP3A4—Benzphetamine—obesity	0.00333	0.0139	CbGbCtD
Bromocriptine—CYP3A4—Bupropion—obesity	0.00283	0.0118	CbGbCtD
Bromocriptine—CYP3A4—Orlistat—obesity	0.00231	0.00965	CbGbCtD
Bromocriptine—CYP3A4—Cimetidine—obesity	0.00208	0.00869	CbGbCtD
Bromocriptine—CYP3A4—Topiramate—obesity	0.00136	0.00569	CbGbCtD
Bromocriptine—HTR7—sympathetic nervous system—obesity	0.00119	0.0838	CbGeAlD
Bromocriptine—HTR7—vagus nerve—obesity	0.00115	0.0812	CbGeAlD
Bromocriptine—HTR7—autonomic nervous system—obesity	0.000801	0.0564	CbGeAlD
Bromocriptine—HTR2A—sympathetic nervous system—obesity	0.000743	0.0523	CbGeAlD
Bromocriptine—HTR2A—vagus nerve—obesity	0.00072	0.0506	CbGeAlD
Bromocriptine—HTR2A—autonomic nervous system—obesity	0.0005	0.0351	CbGeAlD
Bromocriptine—HTR1A—hindbrain—obesity	0.000353	0.0248	CbGeAlD
Bromocriptine—HTR7—hindbrain—obesity	0.000338	0.0237	CbGeAlD
Bromocriptine—ADRA1A—hindbrain—obesity	0.000326	0.0229	CbGeAlD
Bromocriptine—DRD2—hindbrain—obesity	0.000319	0.0224	CbGeAlD
Bromocriptine—Ergoloid mesylate—DRD1—obesity	0.000273	0.142	CrCbGaD
Bromocriptine—DRD5—endocrine gland—obesity	0.000227	0.016	CbGeAlD
Bromocriptine—Dihydroergotamine—HTR1B—obesity	0.000217	0.113	CrCbGaD
Bromocriptine—HTR2A—hindbrain—obesity	0.000211	0.0148	CbGeAlD
Bromocriptine—HTR7—respiratory system—obesity	0.000206	0.0145	CbGeAlD
Bromocriptine—HTR1B—cardiovascular system—obesity	0.000205	0.0144	CbGeAlD
Bromocriptine—HTR2B—adrenal cortex—obesity	0.000202	0.0142	CbGeAlD
Bromocriptine—HTR1D—cardiovascular system—obesity	0.000198	0.0139	CbGeAlD
Bromocriptine—DRD2—respiratory system—obesity	0.000195	0.0137	CbGeAlD
Bromocriptine—ADRB1—cardiovascular system—obesity	0.000193	0.0135	CbGeAlD
Bromocriptine—Ergoloid mesylate—DRD2—obesity	0.000193	0.1	CrCbGaD
Bromocriptine—HTR2B—cardiovascular system—obesity	0.000184	0.013	CbGeAlD
Bromocriptine—ADRA1D—endocrine gland—obesity	0.000182	0.0128	CbGeAlD
Bromocriptine—ADRB1—adipose tissue—obesity	0.00017	0.0119	CbGeAlD
Bromocriptine—Methylergometrine—DRD1—obesity	0.000165	0.0863	CrCbGaD
Bromocriptine—HTR1A—cardiovascular system—obesity	0.000165	0.0116	CbGeAlD
Bromocriptine—CYP1A2—respiratory system—obesity	0.000164	0.0116	CbGeAlD
Bromocriptine—HTR2B—adipose tissue—obesity	0.000163	0.0114	CbGeAlD
Bromocriptine—Ergonovine—HTR2C—obesity	0.000162	0.0845	CrCbGaD
Bromocriptine—ADRA2A—islet of Langerhans—obesity	0.00016	0.0113	CbGeAlD
Bromocriptine—ADRA2C—adrenal cortex—obesity	0.000159	0.0112	CbGeAlD
Bromocriptine—HTR7—cardiovascular system—obesity	0.000158	0.0111	CbGeAlD
Bromocriptine—HTR2B—digestive system—obesity	0.000153	0.0108	CbGeAlD
Bromocriptine—ADRA1A—cardiovascular system—obesity	0.000152	0.0107	CbGeAlD
Bromocriptine—HTR2B—adrenal gland—obesity	0.000146	0.0103	CbGeAlD
Bromocriptine—Methysergide—HTR1B—obesity	0.000145	0.0756	CrCbGaD
Bromocriptine—Methylergometrine—HTR2C—obesity	0.000142	0.0739	CrCbGaD
Bromocriptine—HTR1B—endocrine gland—obesity	0.00014	0.00988	CbGeAlD
Bromocriptine—ADRA1A—adipose tissue—obesity	0.000134	0.00944	CbGeAlD
Bromocriptine—DRD2—pituitary gland—obesity	0.000132	0.0093	CbGeAlD
Bromocriptine—ADRB1—endocrine gland—obesity	0.000132	0.00929	CbGeAlD
Bromocriptine—HTR7—digestive system—obesity	0.000131	0.00922	CbGeAlD
Bromocriptine—HTR1A—adrenal gland—obesity	0.000131	0.00919	CbGeAlD
Bromocriptine—HTR2A—respiratory system—obesity	0.000129	0.00904	CbGeAlD
Bromocriptine—ADRA2C—pituitary gland—obesity	0.000129	0.00904	CbGeAlD
Bromocriptine—ADRA2C—adipose tissue—obesity	0.000128	0.009	CbGeAlD
Bromocriptine—HTR7—adrenal gland—obesity	0.000125	0.00878	CbGeAlD
Bromocriptine—ADRA1A—adrenal gland—obesity	0.00012	0.00847	CbGeAlD
Bromocriptine—Methysergide—HTR2C—obesity	0.000118	0.0616	CrCbGaD
Bromocriptine—ADRA2C—adrenal gland—obesity	0.000115	0.00807	CbGeAlD
Bromocriptine—HTR1A—endocrine gland—obesity	0.000113	0.00797	CbGeAlD
Bromocriptine—Ergotamine—HTR1B—obesity	0.000112	0.0584	CrCbGaD
Bromocriptine—HTR7—endocrine gland—obesity	0.000108	0.00762	CbGeAlD
Bromocriptine—CYP1A2—digestive system—obesity	0.000105	0.00735	CbGeAlD
Bromocriptine—ADRA1A—endocrine gland—obesity	0.000104	0.00735	CbGeAlD
Bromocriptine—ADRA2A—pituitary gland—obesity	0.000103	0.00721	CbGeAlD
Bromocriptine—DRD2—endocrine gland—obesity	0.000102	0.0072	CbGeAlD
Bromocriptine—ADRA2A—adipose tissue—obesity	0.000102	0.00718	CbGeAlD
Bromocriptine—HTR2A—cardiovascular system—obesity	9.85e-05	0.00692	CbGeAlD
Bromocriptine—HTR7—liver—obesity	9.77e-05	0.00687	CbGeAlD
Bromocriptine—ADRA1A—liver—obesity	9.42e-05	0.00662	CbGeAlD
Bromocriptine—ADRA2A—adrenal gland—obesity	9.16e-05	0.00644	CbGeAlD
Bromocriptine—Ergotamine—HTR2C—obesity	9.12e-05	0.0476	CrCbGaD
Bromocriptine—Methylergometrine—HTR2A—obesity	9.01e-05	0.047	CrCbGaD
Bromocriptine—ADRA2C—liver—obesity	8.98e-05	0.00631	CbGeAlD
Bromocriptine—ABCB1—islet of Langerhans—obesity	8.92e-05	0.00627	CbGeAlD
Bromocriptine—Sinusitis—Sibutramine—obesity	8.92e-05	0.00123	CcSEcCtD
Bromocriptine—Abdominal discomfort—Bupropion—obesity	8.91e-05	0.00122	CcSEcCtD
Bromocriptine—HTR2A—pituitary gland—obesity	8.72e-05	0.00613	CbGeAlD
Bromocriptine—Vomiting—Phentermine—obesity	8.71e-05	0.0012	CcSEcCtD
Bromocriptine—Bradycardia—Sibutramine—obesity	8.68e-05	0.00119	CcSEcCtD
Bromocriptine—Oedema peripheral—Orlistat—obesity	8.68e-05	0.00119	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Topiramate—obesity	8.67e-05	0.00119	CcSEcCtD
Bromocriptine—Rash—Phentermine—obesity	8.64e-05	0.00119	CcSEcCtD
Bromocriptine—CYP1A2—endocrine gland—obesity	8.64e-05	0.00607	CbGeAlD
Bromocriptine—Dermatitis—Phentermine—obesity	8.63e-05	0.00119	CcSEcCtD
Bromocriptine—Headache—Phentermine—obesity	8.59e-05	0.00118	CcSEcCtD
Bromocriptine—Pollakiuria—Bupropion—obesity	8.58e-05	0.00118	CcSEcCtD
Bromocriptine—Rhinitis—Sibutramine—obesity	8.55e-05	0.00118	CcSEcCtD
Bromocriptine—Nausea—Phenylpropanolamine—obesity	8.51e-05	0.00117	CcSEcCtD
Bromocriptine—Hypoaesthesia—Sibutramine—obesity	8.49e-05	0.00117	CcSEcCtD
Bromocriptine—ABCB1—respiratory system—obesity	8.43e-05	0.00592	CbGeAlD
Bromocriptine—Oedema peripheral—Sibutramine—obesity	8.4e-05	0.00115	CcSEcCtD
Bromocriptine—Visual impairment—Sibutramine—obesity	8.22e-05	0.00113	CcSEcCtD
Bromocriptine—HTR2A—digestive system—obesity	8.17e-05	0.00575	CbGeAlD
Bromocriptine—Acute coronary syndrome—Bupropion—obesity	8.17e-05	0.00112	CcSEcCtD
Bromocriptine—Diarrhoea—Diethylpropion—obesity	8.16e-05	0.00112	CcSEcCtD
Bromocriptine—Nausea—Phentermine—obesity	8.14e-05	0.00112	CcSEcCtD
Bromocriptine—Asthenia—Cimetidine—obesity	8.14e-05	0.00112	CcSEcCtD
Bromocriptine—Myocardial infarction—Bupropion—obesity	8.12e-05	0.00112	CcSEcCtD
Bromocriptine—Eye disorder—Sibutramine—obesity	7.97e-05	0.0011	CcSEcCtD
Bromocriptine—Tinnitus—Sibutramine—obesity	7.95e-05	0.00109	CcSEcCtD
Bromocriptine—Mediastinal disorder—Orlistat—obesity	7.94e-05	0.00109	CcSEcCtD
Bromocriptine—ADRA2A—endocrine gland—obesity	7.94e-05	0.00559	CbGeAlD
Bromocriptine—Dizziness—Diethylpropion—obesity	7.88e-05	0.00108	CcSEcCtD
Bromocriptine—Diabetes mellitus—Topiramate—obesity	7.87e-05	0.00108	CcSEcCtD
Bromocriptine—Alopecia—Orlistat—obesity	7.79e-05	0.00107	CcSEcCtD
Bromocriptine—HTR2A—adrenal gland—obesity	7.79e-05	0.00548	CbGeAlD
Bromocriptine—CYP1A2—liver—obesity	7.79e-05	0.00548	CbGeAlD
Bromocriptine—Sinusitis—Bupropion—obesity	7.77e-05	0.00107	CcSEcCtD
Bromocriptine—Diarrhoea—Cimetidine—obesity	7.76e-05	0.00107	CcSEcCtD
Bromocriptine—Angiopathy—Sibutramine—obesity	7.74e-05	0.00106	CcSEcCtD
Bromocriptine—Mental disorder—Orlistat—obesity	7.72e-05	0.00106	CcSEcCtD
Bromocriptine—Arrhythmia—Sibutramine—obesity	7.62e-05	0.00105	CcSEcCtD
Bromocriptine—Vomiting—Diethylpropion—obesity	7.58e-05	0.00104	CcSEcCtD
Bromocriptine—CYP3A4—digestive system—obesity	7.57e-05	0.00532	CbGeAlD
Bromocriptine—Alopecia—Sibutramine—obesity	7.54e-05	0.00104	CcSEcCtD
Bromocriptine—Methysergide—HTR2A—obesity	7.52e-05	0.0393	CrCbGaD
Bromocriptine—Nasal congestion—Topiramate—obesity	7.52e-05	0.00103	CcSEcCtD
Bromocriptine—Ergotamine—DRD2—obesity	7.52e-05	0.0392	CrCbGaD
Bromocriptine—Rash—Diethylpropion—obesity	7.52e-05	0.00103	CcSEcCtD
Bromocriptine—Dysgeusia—Orlistat—obesity	7.51e-05	0.00103	CcSEcCtD
Bromocriptine—Dermatitis—Diethylpropion—obesity	7.51e-05	0.00103	CcSEcCtD
Bromocriptine—Dizziness—Cimetidine—obesity	7.5e-05	0.00103	CcSEcCtD
Bromocriptine—Headache—Diethylpropion—obesity	7.47e-05	0.00103	CcSEcCtD
Bromocriptine—Rhinitis—Bupropion—obesity	7.46e-05	0.00102	CcSEcCtD
Bromocriptine—Hypoaesthesia—Bupropion—obesity	7.4e-05	0.00102	CcSEcCtD
Bromocriptine—Hallucination—Bupropion—obesity	7.4e-05	0.00102	CcSEcCtD
Bromocriptine—Muscle spasms—Orlistat—obesity	7.38e-05	0.00101	CcSEcCtD
Bromocriptine—Oedema peripheral—Bupropion—obesity	7.33e-05	0.00101	CcSEcCtD
Bromocriptine—Connective tissue disorder—Bupropion—obesity	7.31e-05	0.001	CcSEcCtD
Bromocriptine—Tension—Sibutramine—obesity	7.29e-05	0.001	CcSEcCtD
Bromocriptine—Dysgeusia—Sibutramine—obesity	7.27e-05	0.000999	CcSEcCtD
Bromocriptine—Vision blurred—Orlistat—obesity	7.23e-05	0.000994	CcSEcCtD
Bromocriptine—Visual disturbance—Topiramate—obesity	7.23e-05	0.000993	CcSEcCtD
Bromocriptine—Nervousness—Sibutramine—obesity	7.21e-05	0.000991	CcSEcCtD
Bromocriptine—Vomiting—Cimetidine—obesity	7.21e-05	0.000991	CcSEcCtD
Bromocriptine—Visual impairment—Bupropion—obesity	7.17e-05	0.000985	CcSEcCtD
Bromocriptine—Rash—Cimetidine—obesity	7.15e-05	0.000983	CcSEcCtD
Bromocriptine—Dermatitis—Cimetidine—obesity	7.15e-05	0.000982	CcSEcCtD
Bromocriptine—Muscle spasms—Sibutramine—obesity	7.14e-05	0.000981	CcSEcCtD
Bromocriptine—Headache—Cimetidine—obesity	7.11e-05	0.000977	CcSEcCtD
Bromocriptine—Nausea—Diethylpropion—obesity	7.08e-05	0.000973	CcSEcCtD
Bromocriptine—ABCB1—adrenal cortex—obesity	7.07e-05	0.00497	CbGeAlD
Bromocriptine—Hypoglycaemia—Topiramate—obesity	7.02e-05	0.000964	CcSEcCtD
Bromocriptine—Vision blurred—Sibutramine—obesity	7e-05	0.000962	CcSEcCtD
Bromocriptine—Lethargy—Topiramate—obesity	6.99e-05	0.000961	CcSEcCtD
Bromocriptine—Eye disorder—Bupropion—obesity	6.95e-05	0.000955	CcSEcCtD
Bromocriptine—Tinnitus—Bupropion—obesity	6.93e-05	0.000953	CcSEcCtD
Bromocriptine—Cardiac disorder—Bupropion—obesity	6.9e-05	0.000949	CcSEcCtD
Bromocriptine—Vertigo—Orlistat—obesity	6.89e-05	0.000947	CcSEcCtD
Bromocriptine—Diplopia—Topiramate—obesity	6.85e-05	0.000941	CcSEcCtD
Bromocriptine—Agitation—Sibutramine—obesity	6.82e-05	0.000938	CcSEcCtD
Bromocriptine—Disturbance in sexual arousal—Topiramate—obesity	6.8e-05	0.000934	CcSEcCtD
Bromocriptine—HTR2A—endocrine gland—obesity	6.75e-05	0.00475	CbGeAlD
Bromocriptine—Angiopathy—Bupropion—obesity	6.75e-05	0.000927	CcSEcCtD
Bromocriptine—Nausea—Cimetidine—obesity	6.74e-05	0.000926	CcSEcCtD
Bromocriptine—Mediastinal disorder—Bupropion—obesity	6.7e-05	0.000921	CcSEcCtD
Bromocriptine—Psychotic disorder—Topiramate—obesity	6.69e-05	0.000919	CcSEcCtD
Bromocriptine—Vertigo—Sibutramine—obesity	6.67e-05	0.000917	CcSEcCtD
Bromocriptine—Syncope—Sibutramine—obesity	6.66e-05	0.000915	CcSEcCtD
Bromocriptine—Convulsion—Orlistat—obesity	6.65e-05	0.000914	CcSEcCtD
Bromocriptine—Arrhythmia—Bupropion—obesity	6.64e-05	0.000913	CcSEcCtD
Bromocriptine—Alopecia—Bupropion—obesity	6.57e-05	0.000903	CcSEcCtD
Bromocriptine—Loss of consciousness—Sibutramine—obesity	6.53e-05	0.000897	CcSEcCtD
Bromocriptine—Mental disorder—Bupropion—obesity	6.52e-05	0.000895	CcSEcCtD
Bromocriptine—Urinary retention—Topiramate—obesity	6.51e-05	0.000895	CcSEcCtD
Bromocriptine—Anxiety—Orlistat—obesity	6.51e-05	0.000895	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	6.49e-05	0.000892	CcSEcCtD
Bromocriptine—ABCB1—cardiovascular system—obesity	6.45e-05	0.00454	CbGeAlD
Bromocriptine—Ataxia—Topiramate—obesity	6.44e-05	0.000885	CcSEcCtD
Bromocriptine—Convulsion—Sibutramine—obesity	6.43e-05	0.000884	CcSEcCtD
Bromocriptine—Hypertension—Sibutramine—obesity	6.41e-05	0.000881	CcSEcCtD
Bromocriptine—Dry mouth—Orlistat—obesity	6.39e-05	0.000878	CcSEcCtD
Bromocriptine—Tension—Bupropion—obesity	6.35e-05	0.000873	CcSEcCtD
Bromocriptine—Dysgeusia—Bupropion—obesity	6.34e-05	0.000871	CcSEcCtD
Bromocriptine—Anxiety—Sibutramine—obesity	6.3e-05	0.000866	CcSEcCtD
Bromocriptine—Nervousness—Bupropion—obesity	6.29e-05	0.000864	CcSEcCtD
Bromocriptine—Oedema—Orlistat—obesity	6.26e-05	0.000861	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Topiramate—obesity	6.26e-05	0.00086	CcSEcCtD
Bromocriptine—Abdominal pain upper—Topiramate—obesity	6.26e-05	0.00086	CcSEcCtD
Bromocriptine—CYP3A4—endocrine gland—obesity	6.25e-05	0.0044	CbGeAlD
Bromocriptine—Muscle spasms—Bupropion—obesity	6.22e-05	0.000855	CcSEcCtD
Bromocriptine—Infection—Orlistat—obesity	6.22e-05	0.000855	CcSEcCtD
Bromocriptine—Dry mouth—Sibutramine—obesity	6.18e-05	0.00085	CcSEcCtD
Bromocriptine—Nervous system disorder—Orlistat—obesity	6.14e-05	0.000844	CcSEcCtD
Bromocriptine—Nasopharyngitis—Topiramate—obesity	6.12e-05	0.000842	CcSEcCtD
Bromocriptine—Confusional state—Sibutramine—obesity	6.11e-05	0.00084	CcSEcCtD
Bromocriptine—Vision blurred—Bupropion—obesity	6.1e-05	0.000838	CcSEcCtD
Bromocriptine—HTR2A—liver—obesity	6.09e-05	0.00428	CbGeAlD
Bromocriptine—Skin disorder—Orlistat—obesity	6.08e-05	0.000836	CcSEcCtD
Bromocriptine—Oedema—Sibutramine—obesity	6.06e-05	0.000833	CcSEcCtD
Bromocriptine—Infection—Sibutramine—obesity	6.02e-05	0.000827	CcSEcCtD
Bromocriptine—Shock—Sibutramine—obesity	5.96e-05	0.000819	CcSEcCtD
Bromocriptine—Agitation—Bupropion—obesity	5.95e-05	0.000818	CcSEcCtD
Bromocriptine—Dysphagia—Topiramate—obesity	5.92e-05	0.000814	CcSEcCtD
Bromocriptine—Tachycardia—Sibutramine—obesity	5.92e-05	0.000813	CcSEcCtD
Bromocriptine—Skin disorder—Sibutramine—obesity	5.89e-05	0.000809	CcSEcCtD
Bromocriptine—Vertigo—Bupropion—obesity	5.82e-05	0.000799	CcSEcCtD
Bromocriptine—Ergotamine—HTR2A—obesity	5.81e-05	0.0303	CrCbGaD
Bromocriptine—Syncope—Bupropion—obesity	5.81e-05	0.000798	CcSEcCtD
Bromocriptine—Anorexia—Sibutramine—obesity	5.78e-05	0.000794	CcSEcCtD
Bromocriptine—ABCB1—pituitary gland—obesity	5.71e-05	0.00402	CbGeAlD
Bromocriptine—Loss of consciousness—Bupropion—obesity	5.69e-05	0.000782	CcSEcCtD
Bromocriptine—ABCB1—adipose tissue—obesity	5.69e-05	0.004	CbGeAlD
Bromocriptine—Abdominal discomfort—Topiramate—obesity	5.68e-05	0.00078	CcSEcCtD
Bromocriptine—Insomnia—Orlistat—obesity	5.66e-05	0.000778	CcSEcCtD
Bromocriptine—Hypotension—Sibutramine—obesity	5.66e-05	0.000778	CcSEcCtD
Bromocriptine—CYP3A4—liver—obesity	5.64e-05	0.00396	CbGeAlD
Bromocriptine—Paraesthesia—Orlistat—obesity	5.62e-05	0.000773	CcSEcCtD
Bromocriptine—Convulsion—Bupropion—obesity	5.61e-05	0.000771	CcSEcCtD
Bromocriptine—Hypertension—Bupropion—obesity	5.59e-05	0.000768	CcSEcCtD
Bromocriptine—Dyspepsia—Orlistat—obesity	5.51e-05	0.000758	CcSEcCtD
Bromocriptine—Anxiety—Bupropion—obesity	5.49e-05	0.000755	CcSEcCtD
Bromocriptine—Insomnia—Sibutramine—obesity	5.48e-05	0.000753	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	5.47e-05	0.000752	CcSEcCtD
Bromocriptine—Pollakiuria—Topiramate—obesity	5.47e-05	0.000752	CcSEcCtD
Bromocriptine—Decreased appetite—Orlistat—obesity	5.44e-05	0.000748	CcSEcCtD
Bromocriptine—Paraesthesia—Sibutramine—obesity	5.44e-05	0.000748	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Orlistat—obesity	5.41e-05	0.000743	CcSEcCtD
Bromocriptine—Dyspnoea—Sibutramine—obesity	5.4e-05	0.000743	CcSEcCtD
Bromocriptine—Fatigue—Orlistat—obesity	5.4e-05	0.000742	CcSEcCtD
Bromocriptine—Dry mouth—Bupropion—obesity	5.39e-05	0.000741	CcSEcCtD
Bromocriptine—Somnolence—Sibutramine—obesity	5.39e-05	0.00074	CcSEcCtD
Bromocriptine—ABCB1—digestive system—obesity	5.36e-05	0.00377	CbGeAlD
Bromocriptine—Dyspepsia—Sibutramine—obesity	5.34e-05	0.000733	CcSEcCtD
Bromocriptine—Confusional state—Bupropion—obesity	5.33e-05	0.000732	CcSEcCtD
Bromocriptine—Oedema—Bupropion—obesity	5.28e-05	0.000726	CcSEcCtD
Bromocriptine—Decreased appetite—Sibutramine—obesity	5.27e-05	0.000724	CcSEcCtD
Bromocriptine—Infection—Bupropion—obesity	5.25e-05	0.000721	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Sibutramine—obesity	5.23e-05	0.000719	CcSEcCtD
Bromocriptine—Shock—Bupropion—obesity	5.2e-05	0.000714	CcSEcCtD
Bromocriptine—Constipation—Sibutramine—obesity	5.18e-05	0.000712	CcSEcCtD
Bromocriptine—Nervous system disorder—Bupropion—obesity	5.18e-05	0.000712	CcSEcCtD
Bromocriptine—Feeling abnormal—Orlistat—obesity	5.16e-05	0.000709	CcSEcCtD
Bromocriptine—Tachycardia—Bupropion—obesity	5.16e-05	0.000709	CcSEcCtD
Bromocriptine—Skin disorder—Bupropion—obesity	5.13e-05	0.000705	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Orlistat—obesity	5.12e-05	0.000704	CcSEcCtD
Bromocriptine—ABCB1—adrenal gland—obesity	5.1e-05	0.00359	CbGeAlD
Bromocriptine—Anorexia—Bupropion—obesity	5.04e-05	0.000692	CcSEcCtD
Bromocriptine—Feeling abnormal—Sibutramine—obesity	4.99e-05	0.000686	CcSEcCtD
Bromocriptine—Urticaria—Orlistat—obesity	4.98e-05	0.000684	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Sibutramine—obesity	4.96e-05	0.000681	CcSEcCtD
Bromocriptine—Sinusitis—Topiramate—obesity	4.95e-05	0.000681	CcSEcCtD
Bromocriptine—Abdominal pain—Orlistat—obesity	4.95e-05	0.00068	CcSEcCtD
Bromocriptine—Body temperature increased—Orlistat—obesity	4.95e-05	0.00068	CcSEcCtD
Bromocriptine—Hypotension—Bupropion—obesity	4.94e-05	0.000679	CcSEcCtD
Bromocriptine—Bradycardia—Topiramate—obesity	4.82e-05	0.000663	CcSEcCtD
Bromocriptine—Urticaria—Sibutramine—obesity	4.81e-05	0.000662	CcSEcCtD
Bromocriptine—Body temperature increased—Sibutramine—obesity	4.79e-05	0.000658	CcSEcCtD
Bromocriptine—Abdominal pain—Sibutramine—obesity	4.79e-05	0.000658	CcSEcCtD
Bromocriptine—Insomnia—Bupropion—obesity	4.78e-05	0.000657	CcSEcCtD
Bromocriptine—Rhinitis—Topiramate—obesity	4.75e-05	0.000653	CcSEcCtD
Bromocriptine—Paraesthesia—Bupropion—obesity	4.74e-05	0.000652	CcSEcCtD
Bromocriptine—Hypoaesthesia—Topiramate—obesity	4.71e-05	0.000648	CcSEcCtD
Bromocriptine—Hallucination—Topiramate—obesity	4.71e-05	0.000648	CcSEcCtD
Bromocriptine—Dyspnoea—Bupropion—obesity	4.71e-05	0.000647	CcSEcCtD
Bromocriptine—Somnolence—Bupropion—obesity	4.7e-05	0.000646	CcSEcCtD
Bromocriptine—Oedema peripheral—Topiramate—obesity	4.67e-05	0.000641	CcSEcCtD
Bromocriptine—Connective tissue disorder—Topiramate—obesity	4.66e-05	0.00064	CcSEcCtD
Bromocriptine—Dyspepsia—Bupropion—obesity	4.65e-05	0.000639	CcSEcCtD
Bromocriptine—Decreased appetite—Bupropion—obesity	4.59e-05	0.000631	CcSEcCtD
Bromocriptine—Visual impairment—Topiramate—obesity	4.57e-05	0.000628	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Bupropion—obesity	4.56e-05	0.000627	CcSEcCtD
Bromocriptine—Fatigue—Bupropion—obesity	4.56e-05	0.000626	CcSEcCtD
Bromocriptine—Constipation—Bupropion—obesity	4.52e-05	0.000621	CcSEcCtD
Bromocriptine—Asthenia—Orlistat—obesity	4.49e-05	0.000617	CcSEcCtD
Bromocriptine—Eye disorder—Topiramate—obesity	4.43e-05	0.000609	CcSEcCtD
Bromocriptine—ABCB1—endocrine gland—obesity	4.43e-05	0.00311	CbGeAlD
Bromocriptine—Tinnitus—Topiramate—obesity	4.42e-05	0.000607	CcSEcCtD
Bromocriptine—Cardiac disorder—Topiramate—obesity	4.4e-05	0.000604	CcSEcCtD
Bromocriptine—Feeling abnormal—Bupropion—obesity	4.35e-05	0.000598	CcSEcCtD
Bromocriptine—Asthenia—Sibutramine—obesity	4.35e-05	0.000598	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Bupropion—obesity	4.32e-05	0.000594	CcSEcCtD
Bromocriptine—Angiopathy—Topiramate—obesity	4.3e-05	0.000591	CcSEcCtD
Bromocriptine—Diarrhoea—Orlistat—obesity	4.29e-05	0.000589	CcSEcCtD
Bromocriptine—Mediastinal disorder—Topiramate—obesity	4.27e-05	0.000587	CcSEcCtD
Bromocriptine—Urticaria—Bupropion—obesity	4.2e-05	0.000577	CcSEcCtD
Bromocriptine—Alopecia—Topiramate—obesity	4.19e-05	0.000575	CcSEcCtD
Bromocriptine—Abdominal pain—Bupropion—obesity	4.18e-05	0.000574	CcSEcCtD
Bromocriptine—Body temperature increased—Bupropion—obesity	4.18e-05	0.000574	CcSEcCtD
Bromocriptine—Mental disorder—Topiramate—obesity	4.15e-05	0.00057	CcSEcCtD
Bromocriptine—Diarrhoea—Sibutramine—obesity	4.15e-05	0.00057	CcSEcCtD
Bromocriptine—Dizziness—Orlistat—obesity	4.14e-05	0.000569	CcSEcCtD
Bromocriptine—Tension—Topiramate—obesity	4.05e-05	0.000556	CcSEcCtD
Bromocriptine—Dysgeusia—Topiramate—obesity	4.04e-05	0.000555	CcSEcCtD
Bromocriptine—Dizziness—Sibutramine—obesity	4.01e-05	0.000551	CcSEcCtD
Bromocriptine—Nervousness—Topiramate—obesity	4.01e-05	0.000551	CcSEcCtD
Bromocriptine—ABCB1—liver—obesity	3.99e-05	0.00281	CbGeAlD
Bromocriptine—Vomiting—Orlistat—obesity	3.98e-05	0.000547	CcSEcCtD
Bromocriptine—Muscle spasms—Topiramate—obesity	3.97e-05	0.000545	CcSEcCtD
Bromocriptine—Rash—Orlistat—obesity	3.95e-05	0.000543	CcSEcCtD
Bromocriptine—Dermatitis—Orlistat—obesity	3.95e-05	0.000542	CcSEcCtD
Bromocriptine—Headache—Orlistat—obesity	3.92e-05	0.000539	CcSEcCtD
Bromocriptine—Vision blurred—Topiramate—obesity	3.89e-05	0.000534	CcSEcCtD
Bromocriptine—Vomiting—Sibutramine—obesity	3.85e-05	0.00053	CcSEcCtD
Bromocriptine—Rash—Sibutramine—obesity	3.82e-05	0.000525	CcSEcCtD
Bromocriptine—Dermatitis—Sibutramine—obesity	3.82e-05	0.000525	CcSEcCtD
Bromocriptine—Headache—Sibutramine—obesity	3.8e-05	0.000522	CcSEcCtD
Bromocriptine—Asthenia—Bupropion—obesity	3.79e-05	0.000521	CcSEcCtD
Bromocriptine—Agitation—Topiramate—obesity	3.79e-05	0.000521	CcSEcCtD
Bromocriptine—Nausea—Orlistat—obesity	3.72e-05	0.000511	CcSEcCtD
Bromocriptine—Vertigo—Topiramate—obesity	3.71e-05	0.000509	CcSEcCtD
Bromocriptine—Syncope—Topiramate—obesity	3.7e-05	0.000508	CcSEcCtD
Bromocriptine—Loss of consciousness—Topiramate—obesity	3.63e-05	0.000498	CcSEcCtD
Bromocriptine—Diarrhoea—Bupropion—obesity	3.62e-05	0.000497	CcSEcCtD
Bromocriptine—Nausea—Sibutramine—obesity	3.6e-05	0.000495	CcSEcCtD
Bromocriptine—Convulsion—Topiramate—obesity	3.57e-05	0.000491	CcSEcCtD
Bromocriptine—Hypertension—Topiramate—obesity	3.56e-05	0.000489	CcSEcCtD
Bromocriptine—Anxiety—Topiramate—obesity	3.5e-05	0.000481	CcSEcCtD
Bromocriptine—Dizziness—Bupropion—obesity	3.49e-05	0.00048	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.49e-05	0.000479	CcSEcCtD
Bromocriptine—Dry mouth—Topiramate—obesity	3.43e-05	0.000472	CcSEcCtD
Bromocriptine—Confusional state—Topiramate—obesity	3.39e-05	0.000466	CcSEcCtD
Bromocriptine—Oedema—Topiramate—obesity	3.37e-05	0.000463	CcSEcCtD
Bromocriptine—Vomiting—Bupropion—obesity	3.36e-05	0.000462	CcSEcCtD
Bromocriptine—Infection—Topiramate—obesity	3.34e-05	0.00046	CcSEcCtD
Bromocriptine—Rash—Bupropion—obesity	3.33e-05	0.000458	CcSEcCtD
Bromocriptine—Dermatitis—Bupropion—obesity	3.33e-05	0.000457	CcSEcCtD
Bromocriptine—Shock—Topiramate—obesity	3.31e-05	0.000455	CcSEcCtD
Bromocriptine—Headache—Bupropion—obesity	3.31e-05	0.000455	CcSEcCtD
Bromocriptine—Nervous system disorder—Topiramate—obesity	3.3e-05	0.000454	CcSEcCtD
Bromocriptine—Tachycardia—Topiramate—obesity	3.29e-05	0.000452	CcSEcCtD
Bromocriptine—Skin disorder—Topiramate—obesity	3.27e-05	0.000449	CcSEcCtD
Bromocriptine—Anorexia—Topiramate—obesity	3.21e-05	0.000441	CcSEcCtD
Bromocriptine—Hypotension—Topiramate—obesity	3.15e-05	0.000432	CcSEcCtD
Bromocriptine—Nausea—Bupropion—obesity	3.14e-05	0.000431	CcSEcCtD
Bromocriptine—Insomnia—Topiramate—obesity	3.04e-05	0.000418	CcSEcCtD
Bromocriptine—Paraesthesia—Topiramate—obesity	3.02e-05	0.000415	CcSEcCtD
Bromocriptine—Dyspnoea—Topiramate—obesity	3e-05	0.000412	CcSEcCtD
Bromocriptine—Somnolence—Topiramate—obesity	2.99e-05	0.000411	CcSEcCtD
Bromocriptine—Dyspepsia—Topiramate—obesity	2.96e-05	0.000407	CcSEcCtD
Bromocriptine—Decreased appetite—Topiramate—obesity	2.93e-05	0.000402	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Topiramate—obesity	2.91e-05	0.000399	CcSEcCtD
Bromocriptine—Fatigue—Topiramate—obesity	2.9e-05	0.000399	CcSEcCtD
Bromocriptine—Constipation—Topiramate—obesity	2.88e-05	0.000396	CcSEcCtD
Bromocriptine—Feeling abnormal—Topiramate—obesity	2.77e-05	0.000381	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Topiramate—obesity	2.75e-05	0.000378	CcSEcCtD
Bromocriptine—Urticaria—Topiramate—obesity	2.67e-05	0.000368	CcSEcCtD
Bromocriptine—Abdominal pain—Topiramate—obesity	2.66e-05	0.000366	CcSEcCtD
Bromocriptine—Body temperature increased—Topiramate—obesity	2.66e-05	0.000366	CcSEcCtD
Bromocriptine—Asthenia—Topiramate—obesity	2.42e-05	0.000332	CcSEcCtD
Bromocriptine—Diarrhoea—Topiramate—obesity	2.3e-05	0.000317	CcSEcCtD
Bromocriptine—Dizziness—Topiramate—obesity	2.23e-05	0.000306	CcSEcCtD
Bromocriptine—Vomiting—Topiramate—obesity	2.14e-05	0.000294	CcSEcCtD
Bromocriptine—Rash—Topiramate—obesity	2.12e-05	0.000292	CcSEcCtD
Bromocriptine—Dermatitis—Topiramate—obesity	2.12e-05	0.000291	CcSEcCtD
Bromocriptine—Headache—Topiramate—obesity	2.11e-05	0.00029	CcSEcCtD
Bromocriptine—Nausea—Topiramate—obesity	2e-05	0.000275	CcSEcCtD
Bromocriptine—HTR2A—Signaling Pathways—PIK3R1—obesity	4.85e-07	7.08e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOS3—obesity	4.85e-07	7.08e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TYK2—obesity	4.83e-07	7.06e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PTGS2—obesity	4.82e-07	7.05e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CAV1—obesity	4.82e-07	7.05e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOA1—obesity	4.81e-07	7.03e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP2E1—obesity	4.81e-07	7.03e-06	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—AKT1—obesity	4.81e-07	7.02e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MYC—obesity	4.8e-07	7.02e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RHOA—obesity	4.79e-07	7.01e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—obesity	4.79e-07	7e-06	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—AKT1—obesity	4.78e-07	6.99e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NQO1—obesity	4.75e-07	6.95e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3R1—obesity	4.74e-07	6.93e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOS3—obesity	4.74e-07	6.93e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—obesity	4.73e-07	6.91e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—obesity	4.71e-07	6.88e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—obesity	4.7e-07	6.88e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—PIK3CA—obesity	4.69e-07	6.86e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CD—obesity	4.67e-07	6.82e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—obesity	4.66e-07	6.81e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—obesity	4.65e-07	6.8e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AKT1—obesity	4.65e-07	6.8e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—LPL—obesity	4.63e-07	6.77e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	4.62e-07	6.76e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SERPINE1—obesity	4.62e-07	6.75e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—PIK3CA—obesity	4.62e-07	6.75e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—obesity	4.59e-07	6.71e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—obesity	4.59e-07	6.71e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MYC—obesity	4.58e-07	6.7e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—obesity	4.58e-07	6.69e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AKT1—obesity	4.58e-07	6.69e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK8—obesity	4.58e-07	6.69e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—obesity	4.57e-07	6.68e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AKT1—obesity	4.56e-07	6.67e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GCG—obesity	4.56e-07	6.66e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SLC2A4—obesity	4.56e-07	6.66e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CB—obesity	4.55e-07	6.64e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MTOR—obesity	4.55e-07	6.64e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK8—obesity	4.53e-07	6.63e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GPX1—obesity	4.52e-07	6.61e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AKT1—obesity	4.52e-07	6.61e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	4.52e-07	6.6e-06	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AKT1—obesity	4.51e-07	6.59e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—obesity	4.51e-07	6.58e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—obesity	4.5e-07	6.58e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYCS—obesity	4.5e-07	6.57e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TYK2—obesity	4.49e-07	6.56e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—obesity	4.48e-07	6.54e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CB—obesity	4.47e-07	6.54e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MTOR—obesity	4.47e-07	6.54e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RHOA—obesity	4.45e-07	6.51e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GGT1—obesity	4.41e-07	6.45e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GOT1—obesity	4.41e-07	6.45e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOS3—obesity	4.41e-07	6.44e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3R1—obesity	4.41e-07	6.44e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CD36—obesity	4.4e-07	6.44e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CG—obesity	4.39e-07	6.42e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MTOR—obesity	4.38e-07	6.4e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CB—obesity	4.38e-07	6.4e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK8—obesity	4.38e-07	6.4e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AKT1—obesity	4.36e-07	6.38e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—obesity	4.35e-07	6.36e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK8—obesity	4.35e-07	6.36e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NCOA1—obesity	4.35e-07	6.35e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AKT1—obesity	4.34e-07	6.35e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—obesity	4.32e-07	6.32e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—obesity	4.31e-07	6.3e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—obesity	4.29e-07	6.26e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—STK11—obesity	4.29e-07	6.26e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP19A1—obesity	4.29e-07	6.26e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—obesity	4.27e-07	6.23e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—obesity	4.27e-07	6.23e-06	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PIK3CA—obesity	4.26e-07	6.23e-06	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PIK3CA—obesity	4.26e-07	6.22e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—obesity	4.26e-07	6.22e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—obesity	4.26e-07	6.22e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARG—obesity	4.24e-07	6.19e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK8—obesity	4.23e-07	6.19e-06	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PIK3CA—obesity	4.23e-07	6.18e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—obesity	4.22e-07	6.17e-06	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—obesity	4.22e-07	6.17e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	4.2e-07	6.14e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—obesity	4.18e-07	6.11e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—POMC—obesity	4.18e-07	6.11e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MTHFR—obesity	4.17e-07	6.1e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK8—obesity	4.17e-07	6.09e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—INS—obesity	4.16e-07	6.08e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—obesity	4.16e-07	6.07e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—obesity	4.15e-07	6.07e-06	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—obesity	4.15e-07	6.07e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—obesity	4.14e-07	6.06e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—obesity	4.14e-07	6.05e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARA—obesity	4.09e-07	5.98e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—obesity	4.09e-07	5.97e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—obesity	4.08e-07	5.96e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MTOR—obesity	4.07e-07	5.95e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CB—obesity	4.07e-07	5.95e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—obesity	4.07e-07	5.94e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—obesity	4e-07	5.85e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—obesity	4e-07	5.85e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—COMT—obesity	3.98e-07	5.82e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—obesity	3.98e-07	5.82e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AGT—obesity	3.96e-07	5.79e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—obesity	3.95e-07	5.77e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GNB3—obesity	3.93e-07	5.74e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARGC1A—obesity	3.93e-07	5.74e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HMOX1—obesity	3.91e-07	5.72e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—obesity	3.89e-07	5.69e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—obesity	3.89e-07	5.68e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—obesity	3.89e-07	5.68e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—obesity	3.88e-07	5.68e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—obesity	3.88e-07	5.67e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—obesity	3.87e-07	5.66e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—obesity	3.86e-07	5.64e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—obesity	3.85e-07	5.63e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAV1—obesity	3.85e-07	5.62e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK8—obesity	3.84e-07	5.62e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—obesity	3.84e-07	5.61e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOA1—obesity	3.84e-07	5.61e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—obesity	3.83e-07	5.6e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GNAS—obesity	3.82e-07	5.59e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—obesity	3.81e-07	5.57e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—obesity	3.81e-07	5.57e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—obesity	3.81e-07	5.56e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK8—obesity	3.78e-07	5.53e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—obesity	3.78e-07	5.52e-06	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—obesity	3.78e-07	5.52e-06	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—obesity	3.77e-07	5.51e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—obesity	3.77e-07	5.51e-06	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—obesity	3.75e-07	5.48e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOB—obesity	3.75e-07	5.47e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—obesity	3.72e-07	5.43e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—obesity	3.72e-07	5.43e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—obesity	3.71e-07	5.42e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK8—obesity	3.7e-07	5.41e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—obesity	3.7e-07	5.41e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—obesity	3.69e-07	5.4e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—obesity	3.69e-07	5.39e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.68e-07	5.37e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—obesity	3.67e-07	5.36e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—obesity	3.67e-07	5.36e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—obesity	3.65e-07	5.34e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—obesity	3.65e-07	5.33e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3R1—obesity	3.65e-07	5.33e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—obesity	3.62e-07	5.29e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—obesity	3.62e-07	5.29e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—obesity	3.61e-07	5.28e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—obesity	3.6e-07	5.26e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—obesity	3.59e-07	5.24e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—LPL—obesity	3.58e-07	5.23e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—obesity	3.54e-07	5.17e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—obesity	3.54e-07	5.17e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—obesity	3.53e-07	5.16e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—obesity	3.51e-07	5.13e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—obesity	3.51e-07	5.12e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX1—obesity	3.49e-07	5.1e-06	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—obesity	3.48e-07	5.09e-06	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—obesity	3.48e-07	5.08e-06	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—obesity	3.46e-07	5.05e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—obesity	3.46e-07	5.05e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—obesity	3.45e-07	5.04e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK8—obesity	3.44e-07	5.03e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—obesity	3.43e-07	5.01e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CD36—obesity	3.4e-07	4.97e-06	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—obesity	3.38e-07	4.95e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—obesity	3.38e-07	4.95e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—obesity	3.38e-07	4.95e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—obesity	3.36e-07	4.92e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—POMC—obesity	3.34e-07	4.88e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—obesity	3.33e-07	4.87e-06	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—obesity	3.33e-07	4.87e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—INS—obesity	3.32e-07	4.85e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—obesity	3.3e-07	4.82e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—obesity	3.27e-07	4.78e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—obesity	3.26e-07	4.77e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—obesity	3.26e-07	4.76e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—obesity	3.25e-07	4.75e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—obesity	3.22e-07	4.71e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—obesity	3.21e-07	4.69e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—obesity	3.21e-07	4.69e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—obesity	3.21e-07	4.69e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—obesity	3.2e-07	4.68e-06	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—obesity	3.18e-07	4.65e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARA—obesity	3.16e-07	4.62e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—obesity	3.16e-07	4.61e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—obesity	3.14e-07	4.6e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—obesity	3.14e-07	4.6e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—obesity	3.14e-07	4.59e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—obesity	3.14e-07	4.59e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—obesity	3.08e-07	4.5e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AGT—obesity	3.06e-07	4.47e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—obesity	3.05e-07	4.46e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—obesity	3.04e-07	4.45e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.01e-07	4.39e-06	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—obesity	3e-07	4.38e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—obesity	3e-07	4.38e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—obesity	2.98e-07	4.36e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAV1—obesity	2.97e-07	4.34e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—obesity	2.97e-07	4.34e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOA1—obesity	2.96e-07	4.33e-06	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—obesity	2.96e-07	4.32e-06	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—obesity	2.96e-07	4.32e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—obesity	2.92e-07	4.27e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—obesity	2.92e-07	4.27e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—obesity	2.91e-07	4.26e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—obesity	2.91e-07	4.25e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3R1—obesity	2.91e-07	4.25e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—obesity	2.89e-07	4.23e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—obesity	2.79e-07	4.08e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—obesity	2.78e-07	4.06e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—obesity	2.77e-07	4.05e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—obesity	2.73e-07	3.98e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—obesity	2.71e-07	3.95e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—obesity	2.7e-07	3.95e-06	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—obesity	2.7e-07	3.94e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—obesity	2.69e-07	3.93e-06	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—obesity	2.67e-07	3.9e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.67e-07	3.9e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—obesity	2.66e-07	3.89e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—obesity	2.66e-07	3.89e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—obesity	2.61e-07	3.82e-06	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—obesity	2.58e-07	3.77e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—POMC—obesity	2.58e-07	3.76e-06	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—obesity	2.56e-07	3.75e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—INS—obesity	2.56e-07	3.74e-06	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—obesity	2.49e-07	3.65e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—obesity	2.48e-07	3.63e-06	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—obesity	2.46e-07	3.59e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—obesity	2.45e-07	3.59e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—obesity	2.42e-07	3.54e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—obesity	2.41e-07	3.53e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—obesity	2.38e-07	3.48e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—obesity	2.36e-07	3.45e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—obesity	2.35e-07	3.43e-06	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—obesity	2.26e-07	3.31e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3R1—obesity	2.25e-07	3.28e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—obesity	2.25e-07	3.28e-06	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—obesity	2.23e-07	3.26e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—obesity	2.2e-07	3.21e-06	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—obesity	2.18e-07	3.19e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—obesity	2.07e-07	3.03e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—obesity	2.05e-07	3e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—obesity	2.05e-07	3e-06	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—obesity	2.03e-07	2.96e-06	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—obesity	1.68e-07	2.45e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—obesity	1.64e-07	2.39e-06	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—obesity	1.34e-07	1.96e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—obesity	1.26e-07	1.85e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—obesity	1.03e-07	1.51e-06	CbGpPWpGaD
